IL155965A0 - Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative - Google Patents

Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative

Info

Publication number
IL155965A0
IL155965A0 IL15596501A IL15596501A IL155965A0 IL 155965 A0 IL155965 A0 IL 155965A0 IL 15596501 A IL15596501 A IL 15596501A IL 15596501 A IL15596501 A IL 15596501A IL 155965 A0 IL155965 A0 IL 155965A0
Authority
IL
Israel
Prior art keywords
imidazole
pharmaceutical compositions
compositions containing
acid derivative
pharmacologically acceptable
Prior art date
Application number
IL15596501A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26604360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL155965(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL155965A0 publication Critical patent/IL155965A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
IL15596501A 2000-11-21 2001-11-19 Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative IL155965A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000354327 2000-11-21
JP2001164009 2001-05-31
PCT/JP2001/010095 WO2002041890A1 (fr) 2000-11-21 2001-11-19 Compositions medicinales

Publications (1)

Publication Number Publication Date
IL155965A0 true IL155965A0 (en) 2003-12-23

Family

ID=26604360

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15596501A IL155965A0 (en) 2000-11-21 2001-11-19 Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative
IL155965A IL155965A (en) 2000-11-21 2003-05-18 Pharmaceutical preparations containing the result of imidazole converted in position - 5 - in carboxylic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155965A IL155965A (en) 2000-11-21 2003-05-18 Pharmaceutical preparations containing the result of imidazole converted in position - 5 - in carboxylic acid

Country Status (24)

Country Link
US (2) US6878703B2 (fr)
EP (2) EP1336407B1 (fr)
KR (1) KR100656716B1 (fr)
CN (1) CN1265788C (fr)
AT (1) ATE324890T1 (fr)
AU (2) AU1432402A (fr)
BR (1) BR0115516A (fr)
CA (1) CA2429260A1 (fr)
CY (1) CY1106134T1 (fr)
CZ (1) CZ20031367A3 (fr)
DE (1) DE60119368T2 (fr)
DK (1) DK1336407T3 (fr)
ES (1) ES2262689T3 (fr)
HK (1) HK1054692A1 (fr)
HU (1) HUP0400553A3 (fr)
IL (2) IL155965A0 (fr)
MX (1) MXPA03004463A (fr)
NO (1) NO332938B1 (fr)
NZ (1) NZ525913A (fr)
PL (1) PL207252B1 (fr)
PT (1) PT1336407E (fr)
SK (1) SK5992003A3 (fr)
TW (1) TWI262076B (fr)
WO (1) WO2002041890A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3045174A1 (fr) * 2003-01-31 2016-07-20 Daiichi Sankyo Company, Limited Médicament pour la prévention et le traitement de l'artériosclérose et de l'hypertension
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
AU2004270162B2 (en) 2003-08-28 2010-05-13 Nicox S.A. Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CN1976926A (zh) * 2004-09-02 2007-06-06 特瓦制药工业有限公司 奥美沙坦酯的制备
KR100953878B1 (ko) * 2004-09-02 2010-04-22 테바 파마슈티컬 인더스트리즈 리미티드 올메살탄 메독소밀의 정제
CA2597460A1 (fr) 2005-02-24 2006-08-31 Nitromed, Inc. Compositions et composes diuretiques renforcateurs d'oxyde nitrique, et leurs procedes d'utilisation
WO2006123765A1 (fr) * 2005-05-20 2006-11-23 Daiichi Sankyo Company, Limited Preparation recouverte d’un film
TWI367756B (en) * 2005-05-20 2012-07-11 Sankyo Co A film-coated drug product comprising dextrose
WO2007047838A2 (fr) * 2005-10-20 2007-04-26 Dr. Reddy's Laboratories Ltd. Procede de preparation de l'olmesartan medoxomil
US8077769B2 (en) * 2006-03-28 2011-12-13 Sony Corporation Method of reducing computations in transform and scaling processes in a digital video encoder using a threshold-based approach
EP1891952B1 (fr) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Composition pharmaceutique d'olmésartan médoxomil
US20100143470A1 (en) * 2006-10-30 2010-06-10 Hanall Pharmaceutical Company, Ltd Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor blockers
EP2253318B1 (fr) 2008-03-13 2014-08-06 Daiichi Sankyo Company, Limited Amélioration de la solubilité d'une préparation contenant de l'olmésartan médoxomil
US20100008956A1 (en) * 2008-07-08 2010-01-14 Jie Du Composition and combinations of carboxylic acid losartan in dosage forms
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
WO2010075347A2 (fr) 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Méthode de traitement de l'hypertension avec au moins un agent bloquant les récepteurs d'angiotensine ii et de la chlorthalidone
IT1400311B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
EP3807898A1 (fr) 2018-06-14 2021-04-21 AstraZeneca UK Limited Procédés de traitement de l'hypertension au moyen d'une composition pharmaceutique de blocage du récepteur de l'angiotensine ii

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254076A (en) 1966-05-31 Sulfamyl hydro
US3009911A (en) 1961-11-21 Derivatives of j
US2783241A (en) 1957-02-26 S-acylimino-x-substituted-az-i
US3025292A (en) * 1962-03-13 Reduction of i
US2976289A (en) 1961-03-21 X-tetrahydro -
US3108097A (en) * 1963-10-22 Ehnojs
US2554816A (en) 1950-04-04 1951-05-29 American Cyanamid Co Heterocyclic sulfonamides and methods of preparation thereof
GB795174A (en) 1954-10-13 1958-05-21 Upjohn Co Heterocyclic sulphonamides
US2835702A (en) 1956-05-02 1958-05-20 Merck & Co Inc Benzene 1, 3 disulfonamides possessing diuretic properties
US2980679A (en) 1957-04-04 1961-04-18 Omikron Gagliardi Societa Di F Process for preparing heterocyclic sulfonamides
US3055904A (en) 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
GB851287A (en) 1958-07-10 1960-10-12 British Drug Houses Ltd 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
GB979994A (en) * 1961-07-28 1965-01-06 May & Baker Ltd Isoindolinone derivatives
US3265573A (en) 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
BE639386A (fr) * 1962-10-30
DE1278443C2 (de) 1963-11-30 1975-07-24 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-disulfonamid-1-chlorbenzolen
US3163645A (en) 1964-09-25 1964-12-29 Ciba Geigy Corp Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides
DE1270544B (de) * 1965-06-19 1968-06-20 Beiersdorf Ag 4-Chlor-5-sulfamylsalicylsaeure-(2', 6'-dimethyl)-anilid und dessen Alkali- oder Ammonium-Salze sowie Verfahren zu deren Herstellung
US3360518A (en) * 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones
US3634583A (en) * 1969-07-24 1972-01-11 Leo Pharm Prod Ltd Pharmaceutical composition for the treatment of oedematous conditions and hypertension
BE757001A (fr) 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
EP0733366B1 (fr) * 1988-01-07 1998-04-01 E.I. Du Pont De Nemours And Company Compositions pharmaceutiques comprenant des imidazoles comme antagonistes d'angiotensine II et des diurétiques
CA1338238C (fr) * 1988-01-07 1996-04-09 David John Carini Imidazoles bloquant les recepteurs de l'angiotensine ii et combinaisons de ces imidazoles avec des diuretiques et des anti-inflammatoires non steroidiens
EP0400835A1 (fr) * 1989-05-15 1990-12-05 Merck & Co. Inc. Benzimidazoles substitués comme antagoniste d'angiotensine II
US5656650A (en) * 1990-12-14 1997-08-12 Smithkline Beecham Corp. Angiotensin II receptor blocking compositions
FI112942B3 (fi) * 1991-02-21 2012-03-13 Daiichi Sankyo Co Ltd Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist

Also Published As

Publication number Publication date
AU1432402A (en) 2002-06-03
HUP0400553A3 (en) 2010-03-29
NO20032261L (no) 2003-07-09
EP1595540A1 (fr) 2005-11-16
WO2002041890A1 (fr) 2002-05-30
TWI262076B (en) 2006-09-21
US20050113367A1 (en) 2005-05-26
IL155965A (en) 2008-08-07
DE60119368D1 (de) 2006-06-08
SK5992003A3 (en) 2003-11-04
EP1336407A1 (fr) 2003-08-20
PL361093A1 (en) 2004-09-20
CN1265788C (zh) 2006-07-26
US20040002529A1 (en) 2004-01-01
HUP0400553A2 (hu) 2004-06-28
EP1336407A4 (fr) 2004-07-14
KR20030096235A (ko) 2003-12-24
KR100656716B1 (ko) 2006-12-13
CY1106134T1 (el) 2011-06-08
CZ20031367A3 (cs) 2003-10-15
NZ525913A (en) 2004-05-28
ES2262689T3 (es) 2006-12-01
AU2002214324B2 (en) 2004-07-29
ATE324890T1 (de) 2006-06-15
MXPA03004463A (es) 2003-08-19
EP1336407B1 (fr) 2006-05-03
HK1054692A1 (en) 2003-12-12
US6878703B2 (en) 2005-04-12
NO20032261D0 (no) 2003-05-20
DK1336407T3 (da) 2006-09-04
DE60119368T2 (de) 2007-05-03
PL207252B1 (pl) 2010-11-30
CN1486182A (zh) 2004-03-31
NO332938B1 (no) 2013-02-04
CA2429260A1 (fr) 2002-05-30
BR0115516A (pt) 2004-02-03
PT1336407E (pt) 2006-07-31

Similar Documents

Publication Publication Date Title
IL155965A0 (en) Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
YU68102A (sh) Derivati karboksilne kiseline kao ip antagonisti
IL192605A0 (en) 1,2-dihydropyridin-2-one derivatives and pharmaceutical compositions containing the same
DE69232022D1 (de) Naphthyridinderivate als Angiotensin-II-Antagonist-Inhibitoren
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
NZ331060A (en) Quinoxalinediones, preparation and pharmaceutical compositions thereof
WO2001090097A3 (fr) Nouveaux composes possedant une activite anti-inflammatoire, procede de preparation de ceux-ci et compositions pharmaceutiques les contenant
WO2003049690A3 (fr) Inhibiteurs de l'integrase du vih
WO2003082192A3 (fr) Composes et procedes
IL136100A (en) Biphenylamidine derivatives and pharmaceutical compositions containing the same
HK1019334A1 (en) 2-(arylphenyl) amino-imidazoline derivatives
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
WO2002062798A3 (fr) Sels de composes heterocycliques pharmaceutiquement acceptables
TW375525B (en) Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.
TR200003171T2 (tr) 1-[(1-ikameli-4-piperidinyl)methyl]-4-piperidine türevi, hazırlanma prosesi, bu türevi içeren farmasötik terkip ve ara ürünü